Description
Galectin-8, Human Recombinant is available at Gentaur for Next week delivery.
A specific identifier of malignant tissues.
Biomolecule/Target: LGALS8
Alternates names: Gal-8, PCTA1, Po66-CBP, Prostate carcinoma tumor antigen 1, LGALS8
Synonyms: Gal-8, PCTA1, Po66-CBP, Prostate carcinoma tumor antigen 1
Background Information: Galectin-8, also known as prostate-specific membrane antigen (PCTA1), is an additional prostate-specific antigen that is overexpressed only in malignant tumors and therefore is a more specific identifier of malignancies. It is a member of the galectin gene family which mediates both cell-cell and cell matrix interactions in a manner similar to the selectin subgroup of C-type lectins. Recombinant human Galectin-8 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques.
Reconstitution Instructions: N/A
NCBI Gene Symbol: Lgals8
Gene ID: 3964
NCBI Accession: O00214
Additional Information
Size: |
50 μg |
Country of Manufacturing Origin: |
USA |
Country of Animal Origin: |
USA |
Gene Source: |
Human |
Recombinant: |
Yes |
Source: |
E. coli |
Purity by SDS-PAGE: |
≥90% |
Assay: |
SDS-PAGE |
Purity: |
N/A |
Assay 2: |
N/A |
Endotoxin Level: |
N/A |
Activity (Specifications/test method): |
N/A |
Biological activity: |
N/A |
Results: |
N/A |
Molecular Weight: |
37.9 kDa (337 aa, 1-317 aa + His Tag). |
Storage Temperature: |
-80°C |
Shelf Life: |
12 months |
Concentration: |
0.5 mg/ml |
Appearance: |
Liquid |
Handling: |
Centrifuge the vial prior to opening. |